DEMANT Stock Overview
Operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Demant A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 258.80 |
| 52 Week High | DKK 373.50 |
| 52 Week Low | DKK 246.60 |
| Beta | 1.01 |
| 1 Month Change | -2.27% |
| 3 Month Change | -3.43% |
| 1 Year Change | -10.73% |
| 3 Year Change | -21.79% |
| 5 Year Change | 22.65% |
| Change since IPO | 1,427.57% |
Recent News & Updates
An Intrinsic Calculation For Demant A/S (CPH:DEMANT) Suggests It's 45% Undervalued
Dec 16
Demant (CPH:DEMANT) Is Reinvesting At Lower Rates Of Return
Nov 05When Should You Buy Demant A/S (CPH:DEMANT)?
Oct 23Why Investors Shouldn't Be Surprised By Demant A/S' (CPH:DEMANT) P/E
Oct 09Recent updates
An Intrinsic Calculation For Demant A/S (CPH:DEMANT) Suggests It's 45% Undervalued
Dec 16Demant (CPH:DEMANT) Is Reinvesting At Lower Rates Of Return
Nov 05When Should You Buy Demant A/S (CPH:DEMANT)?
Oct 23Why Investors Shouldn't Be Surprised By Demant A/S' (CPH:DEMANT) P/E
Oct 09Is There An Opportunity With Demant A/S' (CPH:DEMANT) 42% Undervaluation?
Sep 12Is Demant (CPH:DEMANT) Using Too Much Debt?
Aug 30Demant (CPH:DEMANT) May Have Issues Allocating Its Capital
Jul 14Here's Why We Think Demant (CPH:DEMANT) Might Deserve Your Attention Today
Jun 30At kr.326, Is It Time To Put Demant A/S (CPH:DEMANT) On Your Watch List?
Jun 16Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 97% Above Its Share Price
Jun 03We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt
May 22Investors Still Waiting For A Pull Back In Demant A/S (CPH:DEMANT)
Apr 26Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Mar 18Capital Allocation Trends At Demant (CPH:DEMANT) Aren't Ideal
Mar 06Here's Why We Think Demant (CPH:DEMANT) Is Well Worth Watching
Feb 22Demant (CPH:DEMANT) Has A Pretty Healthy Balance Sheet
Feb 08Demant A/S (CPH:DEMANT) Not Flying Under The Radar
Jan 22A Look At The Fair Value Of Demant A/S (CPH:DEMANT)
Jan 04Shareholder Returns
| DEMANT | DK Medical Equipment | DK Market | |
|---|---|---|---|
| 7D | -3.9% | -4.0% | -2.2% |
| 1Y | -10.7% | 2.2% | 7.9% |
Return vs Industry: DEMANT underperformed the Danish Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: DEMANT underperformed the Danish Market which returned 7.9% over the past year.
Price Volatility
| DEMANT volatility | |
|---|---|
| DEMANT Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 3.7% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in DK Market | 10.9% |
| 10% least volatile stocks in DK Market | 2.6% |
Stable Share Price: DEMANT has not had significant price volatility in the past 3 months compared to the Danish market.
Volatility Over Time: DEMANT's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 21,501 | Søren Nielsen | www.demant.com |
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.
Demant A/S Fundamentals Summary
| DEMANT fundamental statistics | |
|---|---|
| Market cap | DKK 56.34b |
| Earnings (TTM) | DKK 2.54b |
| Revenue (TTM) | DKK 22.84b |
22.2x
P/E Ratio2.5x
P/S RatioIs DEMANT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DEMANT income statement (TTM) | |
|---|---|
| Revenue | DKK 22.84b |
| Cost of Revenue | DKK 5.80b |
| Gross Profit | DKK 17.04b |
| Other Expenses | DKK 14.50b |
| Earnings | DKK 2.54b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 05, 2025
| Earnings per share (EPS) | 11.64 |
| Gross Margin | 74.61% |
| Net Profit Margin | 11.10% |
| Debt/Equity Ratio | 137.5% |
How did DEMANT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 01:06 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Demant A/S is covered by 50 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Morten Larsen | ABG Sundal Collier |
| Pierre-Yves Gauthier | AlphaValue |
| Gina Francioli | Bank am Bellevue |